Toru Honda

Toru Honda

Auto-generated profile, based on publicly available information

Toru Honda

Department of Radiology, Osaka University Graduate School of Medicine, Osaka, Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2024 in Japanese Journal of Radiology
Verified
Journal Article
Open access
PDF file
ANAtsushi Nakamoto
Atsushi Nakamoto
HOHiromitsu Onishi
Hiromitsu Onishi
TOTakashi Ota
Takashi Ota
THToru Honda
Toru Honda
TTTakahiro Tsuboyama
Takahiro Tsuboyama
NTNoriyuki Tomiyama
Noriyuki Tomiyama
Purpose: To compare image quality and visibility of anatomical structures on contrast-enhanced thin-slice abdominal CT images reconstructed using super-resolution deep learning reconstruction (SR-DLR), deep learning-based reconstruction (DLR), and hybrid iterative reconstruction (HIR) algorithms. Materials and methods: This retrospective study included 54 consecutive patients who underwent contrast-enhanced abdominal CT. Thin-slice images (0.5 mm thickness) were reconstructed using SR-DLR, DLR, and HIR. Objective image noise and contrast-to-noise ratio (CNR) for liver parenchyma relative to muscle were assessed. Two radiologists independently graded image quality using a 5-point rating scale for image noise, sharpness, artifact/blur, and overall image quality. They also graded the visibility of small vessels, main pancreatic duct, ureters, adrenal glands, and right adrenal vein on a 5-point scale. Results: SR-DLR yielded significantly lower objective image noise and higher CNR than DLR and HIR (P < .001). The visual scores of SR-DLR for image noise, sharpness, and overall image quality were significantly higher than those of DLR and HIR for both readers (P < .001). Both readers scored significantly higher on SR-DLR than on HIR for visibility for all structures (P < .01), and at least one reader scored significantly higher on SR-DLR than on DLR for visibility for all structures (P < .05). Conclusion: SR-DLR reduced image noise and improved image quality of thin-slice abdominal CT images compared to HIR and DLR. This technique is expected to enable further detailed evaluation of small structures.

10 September 2020 in Allergo Journal International
Verified
Journal Article
Closed access
PDF file
THT. Honda
T. Honda
KKK. Kuriyama
K. Kuriyama
KKK. Kiso
K. Kiso
KKK. Kishimoto
K. Kishimoto
TTT. Tsuboyama
T. Tsuboyama
MHM. Higashi
M. Higashi

17 April 2025 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
SMShohei Matsumoto
Shohei Matsumoto
TTTakahiro Tsuboyama
Takahiro Tsuboyama
HOHiromitsu Onishi
Hiromitsu Onishi
KKKoki Kaketaka
Koki Kaketaka
TWTetsuya Wakayama
Tetsuya Wakayama
NTNoriyuki Tomiyama
Noriyuki Tomiyama

17 August 2026 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
FDFeier Ding
Feier Ding
ANAtsushi Nakamoto
Atsushi Nakamoto
XZXiaohan Zheng
Xiaohan Zheng
THToru Honda
Toru Honda
GWGongzheng Wang
Gongzheng Wang
NTNoriyuki Tomiyama
Noriyuki Tomiyama
Intermuscular adipose tissue (IMAT) refers to adipose tissue located between muscle groups or beneath the muscle fascia, and its accumulation is closely linked to impaired muscle quality, reduced contractile function, and adverse metabolic profiles, establishing it as a core component of myosteatosis. Unlike subcutaneous and visceral adipose tissue, which reside outside the muscle architecture, IMAT expands within the muscle environment, where local metabolic and mechanical interactions may affect muscle integrity and performance. Elevated IMAT has been associated with diminished strength, impaired mobility, frailty, insulin resistance, and adverse cardiometabolic profiles, underscoring its clinical relevance beyond a passive fat depot. However, IMAT evidence remains dispersed across imaging techniques, anatomical regions, and disease‐specific literatures, limiting a unified understanding of its clinical utility. This review synthesizes current evidence on IMAT biology, imaging‐based quantification, disease‐specific distribution and clinical implications, with emphasis on its value as a risk‐stratification biomarker. Recent advances in medical imaging, including computed tomography (CT), magnetic resonance imaging (MRI), ultrasound and positron emission tomography (PET), have enabled noninvasive and reproducible IMAT quantification. These modalities provide complementary measures of muscle fat infiltration, including CT‐derived area, volume and attenuation; MRI‐based segmentation and proton density fat fraction; ultrasound echo intensity; and PET‐derived metabolic activity. Deep learning–based segmentation methods have improved large‐scale IMAT quantification and reproducibility across anatomical regions. Mechanistically, IMAT is associated with chronic low‐grade inflammation and impaired glucose homeostasis, promoting progressive fat infiltration and muscle degeneration. Human studies indicate that IMAT exhibits an inflammatory secretory profile linked to insulin resistance and metabolic dysfunction. Quantitative imaging shows anatomically heterogeneous IMAT distribution, with frequent involvement of the lower extremities, paraspinal muscles and trunk. Across disease settings, IMAT appears to provide complementary information beyond muscle mass alone by capturing muscle quality and systemic vulnerability. Evidence is strongest in oncology, where elevated IMAT or IMAT‐based ratios have repeatedly been associated with poorer survival, recurrence, treatment toxicity, and reduced treatment tolerance. In metabolic and musculoskeletal disorders, IMAT is consistently related to insulin resistance, reduced strength, impaired mobility, and frailty, whereas cardiovascular evidence suggests prognostic relevance but remains less standardized and more heterogeneous. Clinically, IMAT imaging may help identify patients whose preserved muscle size or body mass index masks poor muscle quality, thereby refining prognostic assessment, perioperative risk evaluation, and selection for nutritional, exercise, metabolic, or treatment strategies. Future efforts should focus on standardized acquisition, automated segmentation, harmonized thresholds, and prospective validation to support integration of IMAT metrics into clinical decision‐making.

16 April 2025 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
KKKoki Kaketaka
Koki Kaketaka
TTTakahiro Tsuboyama
Takahiro Tsuboyama
ヒフヒデユキ フクイ
ヒデユキ フクイ
SMShohei Matsumoto
Shohei Matsumoto
ANAtsushi Nakamoto
Atsushi Nakamoto
NTNoriyuki Tomiyama
Noriyuki Tomiyama

1 January 2026 in Magnetic Resonance in Medical Sciences
Verified
Journal Article
Closed access
ANAtsushi Nakamoto
Atsushi Nakamoto
TOTakashi Ota
Takashi Ota
ヒフヒデユキ フクイ
ヒデユキ フクイ
THToru Honda
Toru Honda
KKKengo Kiso
Kengo Kiso
NTNoriyuki Tomiyama
Noriyuki Tomiyama
MRI has become an increasingly important modality for evaluating the upper urinary tract. Although CT urography remains the standard imaging modality for assessing hematuria, MRI offers distinct advantages, including superior soft-tissue contrast, functional imaging capability, and a radiation-free evaluation, making it particularly valuable in certain clinical scenarios. This review provides a comprehensive overview of MRI of the upper urinary tract, with a focus on upper tract urothelial carcinoma (UTUC). Optimized MRI techniques, including T2-weighted imaging, MR urography, diffusion-weighted imaging (DWI), and contrast-enhanced T1-weighted imaging, are discussed with respect to their complementary roles in tumor detection, characterization, and local staging. MRI findings of UTUC are summarized, emphasizing the role of DWI in improving tumor detection and assessing renal parenchymal invasion. Beyond UTUC, the review addresses MRI features of non-UTUC neoplastic lesions, infectious and inflammatory diseases, and congenital anomalies of the upper urinary tract, underscoring the value of MRI in differential diagnosis. We discuss the potential role of MRI-derived imaging biomarkers, focusing on apparent diffusion coefficient measurements as noninvasive indicators of tumor aggressiveness and invasiveness. We also introduce emerging radiomics approaches as promising, albeit investigational, tools. As technical innovations continue and clinical evidence grows, the role of MRI in the personalized evaluation and management of upper urinary tract diseases is expected to expand.